No physician knows with certainty what payment tactics Medicare will actually be offering physicians, because CMS actually has not decided them yet. Thus the devil will be in the details. Here is what CMS must do.
Medical Economics sat down with John Halamka, MD, MS, to ask questions about the Centers for Medicare & Medicaid Services' issuing of a Final Rule for attesting to Stage 3 of Meaningful Use programs as well as physicians' demands for delays of the 2017 starting.
In this interview, David F. Penson, MD, MPH, discusses the ACA’s impact on urology, the pros and cons of a single-payer system, and why collecting and reporting outcomes data will be crucial going forward.
The annual battle over the Medicare Sustainable Growth Rate (SGR) formula has come to an end. But the program that replaces it will be Medicare’s leap into the world of value-based payment and risk sharing, and the resulting changes will have a massive impact on how physicians are reimbursed.
Finally, I can stop writing about the Medicare SGR formula and efforts to reform it, and you can stop worrying about whether you’re going to get whacked with untenable payment cuts about this time every year.